Literature DB >> 16168593

An infantile-juvenile form of Alexander disease caused by a R79H mutation in GFAP.

Naoko Asahina1, Takayuki Okamoto, Akira Sudo, Naomi Kanazawa, Seiichi Tsujino, Shinji Saitoh.   

Abstract

Alexander disease is a degenerative white matter disorder due to mutations in the glial fibrillary acidic protein (GFAP) gene. It has been classified into three forms based on the age of onset and severity: an infantile, a juvenile, and an adult form. In a 6-year-old patient with a relatively mild form of Alexander disease, we detected a common R79H mutation in GFAP, previously only described in the infantile form. These results suggest the need for further studies of the genotype-phenotype correlation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168593     DOI: 10.1016/j.braindev.2005.05.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  7 in total

1.  A canine orthologue of the human GFAP c.716G>A (p.Arg239His) variant causes Alexander disease in a Labrador retriever.

Authors:  Mario Van Poucke; Valentine Martlé; Leen Van Brantegem; Richard Ducatelle; Luc Van Ham; Sofie Bhatti; Luc J Peelman
Journal:  Eur J Hum Genet       Date:  2015-10-21       Impact factor: 4.246

2.  Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis.

Authors:  Tomokatsu Yoshida; Masayuki Sasaki; Mari Yoshida; Michito Namekawa; Yuji Okamoto; Seiichi Tsujino; Hiroshi Sasayama; Ikuko Mizuta; Masanori Nakagawa
Journal:  J Neurol       Date:  2011-05-01       Impact factor: 4.849

3.  Accumulation of glial fibrillary acidic protein and histone H4 in brain storage bodies of Tibetan terriers with hereditary neuronal ceroid lipofuscinosis.

Authors:  M L Katz; D N Sanders; B P Mooney; Gary S Johnson
Journal:  J Inherit Metab Dis       Date:  2007-11-15       Impact factor: 4.982

4.  GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Authors:  M Prust; J Wang; H Morizono; A Messing; M Brenner; E Gordon; T Hartka; A Sokohl; R Schiffmann; H Gordish-Dressman; R Albin; H Amartino; K Brockman; A Dinopoulos; M T Dotti; D Fain; R Fernandez; J Ferreira; J Fleming; D Gill; M Griebel; H Heilstedt; P Kaplan; D Lewis; M Nakagawa; R Pedersen; A Reddy; Y Sawaishi; M Schneider; E Sherr; Y Takiyama; K Wakabayashi; J R Gorospe; A Vanderver
Journal:  Neurology       Date:  2011-09-14       Impact factor: 11.800

Review 5.  Identification of a novel de novo pathogenic variant in GFAP in an Iranian family with Alexander disease by whole-exome sequencing.

Authors:  Katayoun Heshmatzad; Niloofar Naderi; Tannaz Masoumi; Hamidreza Pouraliakbar; Samira Kalayinia
Journal:  Eur J Med Res       Date:  2022-09-10       Impact factor: 4.981

6.  Infantile Alexander Disease with Late Onset Infantile Spasms and Hypsarrhythmia.

Authors:  J Paprocka; B Rzepka-Migut; N Rzepka; A Jezela-Stanek; E Morava
Journal:  Balkan J Med Genet       Date:  2019-12-21       Impact factor: 0.519

7.  Parental Somatic Mosaicism Uncovers Inheritance of an Apparently De Novo GFAP Mutation.

Authors:  Alice Grossi; Federico Morelli; Marco Di Duca; Francesco Caroli; Isabella Moroni; Davide Tonduti; Tiziana Bachetti; Isabella Ceccherini
Journal:  Front Genet       Date:  2021-12-07       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.